News|Articles|November 2, 2004
- Pharmaceutical Technology-11-02-2004
- Volume 28
- Issue 11
Comparing and Contrasting Barrier Isolator Decontamination Systems
A discussion of the validation and operation of two commercially available vapor-phase hydrogen peroxide decontamination systems is presented, based on a hands-on examination of both systems.
Advertisement
Articles in this issue
about 21 years ago
Still Waiting for Answersabout 21 years ago
November 2004about 21 years ago
In the Spotlight-November 2004about 21 years ago
Searching for a Viable Business Modelabout 21 years ago
FDA Moves To Implement New GMP PoliciesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
FDA Deploys Agentic AI Capabilities for Agency Staff
3
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
